Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6562)
All Articles published online
|
Jan 28, 2010 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2010; 16(4): 418-424 [PMID: 20101765 DOI: 10.3748/wjg.v16.i4.418] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i4/418.htm |
| Number | Citing Articles |
| 1 |
Sen-Yung Hsieh, Jung-Ru He, Ming-Chin Yu, Wei-Chen Lee, Tse-Chin Chen, Shao-Jung Lo, Rabindranath Bera, Chang-Mung Sung, Cheng-Tang Chiu. Secreted ERBB3 Isoforms Are Serum Markers for Early Hepatoma in Patients with Chronic Hepatitis and Cirrhosis. Journal of Proteome Research 2011; 10(10): 4715 doi: 10.1021/pr200519q
|
| 2 |
Soroosh Sabeti, Redouane Ternifi, Nicholas B. Larson, Michael C. Olson, Thomas D. Atwell, Mostafa Fatemi, Azra Alizad. Morphometric analysis of tumor microvessels for detection of hepatocellular carcinoma using contrast-free ultrasound imaging: A feasibility study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1121664
|
| 3 |
Gehan H. Ibrahim, Moushira A. Mahmoud, Nagwa M. Aly. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients. Molecular Biology Reports 2013; 40(12): 7069 doi: 10.1007/s11033-013-2829-3
|
| 4 |
Ahmed M. El-Gohary, Ahmed E. Zeid, Mohamed E. Ibrahim, Fatma I. Dewedar, Essam A. Elzoheiry. Serum microRNA 143 as a potential biomarker for the diagnosis of hepatitis C virus-related hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2019; 31(2): 214 doi: 10.4103/ejim.ejim_82_18
|
| 5 |
Ping Fang, Lijun Du, Decheng Cai. Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma. Medicine 2020; 99(12): e19461 doi: 10.1097/MD.0000000000019461
|
| 6 |
Fayza A. Rahamtalla, Mohammed S. M. Abdalla, Salma B. M. Mudawi, Mohammed A. H. Kheir Elsid, Iman M. Shammat. Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseases. Comparative Clinical Pathology 2018; 27(5): 1133 doi: 10.1007/s00580-018-2709-2
|
| 7 |
Cong Li, Guangbing Li, Ruoyu Miao, Xin Lu, Shouxian Zhong, Xinting Sang, Yilei Mao, Haitao Zhao. Primary liver cancer presenting as pyogenic liver abscess: Characteristics, diagnosis, and management. Journal of Surgical Oncology 2012; 105(7): 687 doi: 10.1002/jso.22103
|
| 8 |
Isabella Angeli-Pahim, Anastasia Chambers, Sergio Duarte, Daiki Soma, Thiago Beduschi, Ilyas Sahin, Steven Hughes, Ali Zarrinpar. Methylated ctDNA Quantification: Noninvasive Approach to Monitoring Hepatocellular Carcinoma Burden. Journal of the American College of Surgeons 2024; 238(4): 770 doi: 10.1097/XCS.0000000000000939
|
| 9 |
Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, Keisuke Koroki, Kengo Kanayama, Susumu Maruta, Takahiro Maeda, Yuko Kusakabe, Kazufumi Kobayashi, Naoya Kanogawa, Soichiro Kiyono, Masato Nakamura, Takayuki Kondo, Tomoko Saito, Ryo Nakagawa, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Ryosuke Muroyama, Shingo Nakamoto, Shin Yasui, Akinobu Tawada, Makoto Arai, Tatsuo Kanda, Hitoshi Maruyama, Naoya Mimura, Jun Kato, Yoh Zen, Masayuki Ohtsuka, Atsushi Iwama, Naoya Kato. The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84117-9
|
| 10 |
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection. The Analyst 2016; 141(1): 36 doi: 10.1039/C5AN01884F
|
| 11 |
Li Zhang, Yao Zhao, Hao Guan, Di Zhang. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis. Cancer Biomarkers 2022; 34(3): 443 doi: 10.3233/CBM-210261
|
| 12 |
Julius Benicky, Miloslav Sanda, Petr Pompach, Jing Wu, Radoslav Goldman. Quantification of Fucosylated Hemopexin and Complement Factor H in Plasma of Patients with Liver Disease. Analytical Chemistry 2014; 86(21): 10716 doi: 10.1021/ac502727s
|
| 13 |
Naima Zayed Mohamed, Hanan Farouk Aly, Hatem Abdel moneim El-Mezayen, Hadeer E. El-Salamony. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicology Reports 2019; 6: 875 doi: 10.1016/j.toxrep.2019.08.007
|
| 14 |
Pei Wang, Qianqian Song, Jie Ren, Weilong Zhang, Yuting Wang, Lin Zhou, Dongmei Wang, Kun Chen, Liping Jiang, Bochao Zhang, Wanqing Chen, Chunfeng Qu, Hong Zhao, Yuchen Jiao. Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection. Science Translational Medicine 2022; 14(672) doi: 10.1126/scitranslmed.abp8704
|
| 15 |
Benzhe Su, Ping Luo, Zhao Yang, Pei Yu, Zaifang Li, Peiyuan Yin, Lina Zhou, Jinhu Fan, Xin Huang, Xiaohui Lin, Youlin Qiao, Guowang Xu. A novel analysis method for biomarker identification based on horizontal relationship: identifying potential biomarkers from large-scale hepatocellular carcinoma metabolomics data. Analytical and Bioanalytical Chemistry 2019; 411(24): 6377 doi: 10.1007/s00216-019-02011-w
|
| 16 |
Wael Mohialddin Ahmed Doush, Juhaina Ahmed Elzein. Surgical Resection of Hepatocellular Carcinoma in Compensated Cirrhotic Liver: The Benefits and Selection Criteria. Sudan Journal of Medical Sciences 2019; 14(4) doi: 10.18502/sjms.v14i4.5902
|
| 17 |
Eman Youssef , Nashwa El-Khouly, Yahia Abdullah Elzahrani , Rehab M. E. Tash , Eman A. Khalifa, Eman S. M. Bayoumy , Mona Khalil, Awatif E. Edreis, Fatma Saffeyeldin Mohamed, Aml E. Abdou, Nora Seliem, Mahmoud Sofy, Sara Fakhrelden, Sohaila M. H. Marmoush, Ghada F. Elmohaseb, Amal A. Elhosary. TGF-1 mRNA, AFP-L3, and Annexin II in the Early and Late Detection of Hepatocellular Carcinoma: The Diagnostic Value. Open Access Macedonian Journal of Medical Sciences 2022; 10(A): 15 doi: 10.3889/oamjms.2022.10814
|
| 18 |
Ryogo Minamimoto, Michio Senda, Takashi Terauchi, Seishi Jinnouchi, Tomio Inoue, Takeshi Iinuma, Takeshi Inoue, Kengo Ito, Hiroshi Iwata, Kimiichi Uno, Shinya Oku, Kazuhiro Oguchi, Eriko Tsukamoto, Rumi Nakashima, Sadahiko Nishizawa, Hiroshi Fukuda, Takeshi Murano, Tsuyoshi Yoshida. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey. Annals of Nuclear Medicine 2011; 25(1): 45 doi: 10.1007/s12149-010-0428-0
|
| 19 |
Ahmed Abdel-Razik, Rania Elhelaly, Rasha Elzehery, Amany El-Diasty, Sally Abed, Dina Elhammady, Ahmed Tawfik. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study. European Journal of Gastroenterology & Hepatology 2016; 28(5): 599 doi: 10.1097/MEG.0000000000000569
|
| 20 |
Yuan Chang, Tianyu Guo, Bo Zhu, Yefu Liu. A novel nomogram for predicting microvascular invasion in hepatocellular carcinoma. Annals of Hepatology 2023; 28(6): 101136 doi: 10.1016/j.aohep.2023.101136
|
| 21 |
Hiroaki Kanzaki, Sadahisa Ogasawara, Tomomi Okubo, Norio Itokawa, Ryohei Yoshino, Kentaro Fujimoto, Tadayoshi Kogure, Sae Yumita, Takamasa Ishino, Keita Ogawa, Terunao Iwanaga, Miyuki Nakagawa, Kisako Fujiwara, Ryuta Kojima, Keisuke Koroki, Masanori Inoue, Kazufumi Kobayashi, Naoya Kanogawa, Soichiro Kiyono, Masato Nakamura, Takayuki Kondo, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Ei Itobayashi, Masanori Atsukawa, Jun Kato, Naoya Kato. Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis. Drugs - Real World Outcomes 2023; 10(4): 513 doi: 10.1007/s40801-023-00379-x
|
| 22 |
Richard L. Hesketh, Andrew X. Zhu, Rahmi Oklu. Hepatocellular Carcinoma. American Journal of Clinical Oncology 2015; 38(4): 431 doi: 10.1097/COC.0000000000000123
|
| 23 |
Sundas Nasreen, Sobia Safeer, Kamaran Khurshid Dar, Saiqa Andleeb, Mubashir Ejaz, Muhammad Adeeb Khan, Shaukat Ali. Etiology of hepatocellular carcinoma and treatment through medicinal plants: a comprehensive review. Oriental Pharmacy and Experimental Medicine 2018; 18(3): 187 doi: 10.1007/s13596-018-0330-1
|
| 24 |
Amal Ahmed Mohamed, Abdellah Abosrie Ali Omar, Rehab R. EL-Awady, Sally Mohamed Aboelsayed Hassan, Waleed Mohamed Soliman Eitah, Rehab Ahmed, Amir khater, Omnia Mohamed Saad Tantawi, Ahmed Abdelhafeez Mohamed. MiR-155 and MiR-665 role as potential non-invasive biomarkers for hepatocellular carcinoma in Egyptian patients with chronic hepatitis C virus infection. Journal of Translational Internal Medicine 2020; 8(1): 32 doi: 10.2478/jtim-2020-0006
|
| 25 |
Xiaochun Jin, Ying Zhang, Hui Wang, Youtao Zhang. Expression and Clinical Values of Serum miR-155 and miR-224 in Chinese Patients with HCV Infection. International Journal of General Medicine 2022; : 1393 doi: 10.2147/IJGM.S344345
|
| 26 |
XUE-QIN MENG, WEI ZHANG, FENG ZHANG, SHENG-YONG YIN, HAI-YANG XIE, LIN ZHOU, SHU-SEN ZHENG. Solanine-induced reactive oxygen species inhibit the growth of human hepatocellular carcinoma HepG2 cells. Oncology Letters 2016; 11(3): 2145 doi: 10.3892/ol.2016.4167
|
| 27 |
Takahiro Maeda, Hiroaki Kanzaki, Tetsuhiro Chiba, Junjie Ao, Kengo Kanayama, Susumu Maruta, Yuko Kusakabe, Tomoko Saito, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Sadahisa Ogasawara, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Ryo Nakagawa, Ryosuke Muroyama, Tatsuo Kanda, Hitoshi Maruyama, Naoya Kato. Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6322-9
|
| 28 |
Heba S. El Deen, Hemmat E. El Haddad. Significance of hepatocyte growth factor concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2015; 27(3): 92 doi: 10.4103/1110-7782.165437
|
| 29 |
Claudia Matteucci, Roberta Sorrentino, Lia Bellis, Giuseppe Maria Ettorre, Valentina Svicher, Roberto Santoro, Giovanni Vennarecci, Alessandra Biasiolo, Patrizia Pontisso, Daria Scacciatelli, Luca Beneduce, Cesare Sarrecchia, Paolo Casalino, Sergio Bernardini, Pasquale Pierimarchi, Enrico Garaci, Claudio Puoti, Guido Rasi. Detection of high levels of Survivin–immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. Hepatology Research 2014; 44(9): 1008 doi: 10.1111/hepr.12239
|
| 30 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
| 31 |
Masaaki Hidaka, Mitsuhisa Takatsuki, Sadayuki Okudaira, Akihiko Soyama, Izumi Muraoka, Takayuki Tanaka, Izumi Yamaguchi, Takanobu Hara, Hisamitsu Miyaaki, Tatsuki Ichikawa, Tomayoshi Hayashi, Ichiro Sakamoto, Kazuhiko Nakao, Tamotsu Kuroki, Takashi Kanematsu, Susumu Eguchi. The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver. Hepatology International 2013; 7(2): 655 doi: 10.1007/s12072-012-9379-y
|
| 32 |
Tsunekazu Oikawa, Kohji Yamada, Akihito Tsubota, Chisato Saeki, Naoko Tago, Chika Nakagawa, Kaoru Ueda, Hiroshi Kamioka, Tomohiko Taniai, Koichiro Haruki, Masanori Nakano, Yuichi Torisu, Toru Ikegami, Kiyotsugu Yoshida, Masayuki Saruta. Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma. Gastro Hep Advances 2023; 2(1): 83 doi: 10.1016/j.gastha.2022.07.020
|
| 33 |
Xiaoping Wang, Qiaoxia Wang. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/9049252
|
| 34 |
Bob Thoolen, Fiebo J.W. ten Kate, Paul J. van Diest, David E. Malarkey, Susan A. Elmore, Robert R. Maronpot. Comparative Histomorphological Review of Rat and Human Hepatocellular Proliferative Lesions. Journal of Toxicologic Pathology 2012; 25(3): 189 doi: 10.1293/tox.25.189
|
| 35 |
Yankuba B. Manga, Fu-Hsiang Ko, Yuh-Shyong Yang, Jia-Yang Hung, Wen-Luh Yang, Haw-Ming Huang, Chi-Chang Wu. Ultra-fast and sensitive silicon nanobelt field-effect transistor for high-throughput screening of alpha-fetoprotein. Sensors and Actuators B: Chemical 2018; 256: 1114 doi: 10.1016/j.snb.2017.10.007
|
| 36 |
Tim Nagel, Florentine Klaus, Ines Gil Ibanez, Henning Wege, Ansgar Lohse, Bernd Meyer. Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma—correlation with liver cancer and liver cirrhosis. Analytical and Bioanalytical Chemistry 2018; 410(30): 7965 doi: 10.1007/s00216-018-1418-7
|
| 37 |
Liang Li, Jianguo Chen, Xin Chen, Jing Tang, Huan Guo, Xiaofeng Wang, Ji Qian, Guijuan Luo, Fangping He, Xiaomei Lu, Yibo Ding, Yingchen Yang, Wentao Huang, Guojun Hou, Ximeng Lin, Qin Ouyang, Hengyu Li, Ruoyu Wang, Feng Jiang, Rui Pu, Jianhua Lu, Mudan Jin, Yexiong Tan, Frank J. Gonzalez, Guangwen Cao, Mengchao Wu, Hao Wen, Tangchun Wu, Li Jin, Lei Chen, Hongyang Wang. Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma. Cancer Letters 2016; 373(2): 234 doi: 10.1016/j.canlet.2016.01.028
|
| 38 |
Amal Saad-Hussein, Safia Beshir, Mona M. Taha, Eman M. Shahy, Weam Shaheen, Ebtesam A. Abdel-Shafy, Eman Thabet. Early prediction of liver carcinogenicity due to occupational exposure to pesticides. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2019; 838: 46 doi: 10.1016/j.mrgentox.2018.12.004
|
| 39 |
Zhen-Ya Lu, Chao Cen, Zhou Shao, Xin-Hua Chen, Cheng-Fu Xu, You-Ming Li. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study. World Journal of Gastroenterology 2016; 22(5): 1884-1890 doi: 10.3748/wjg.v22.i5.1884
|
| 40 |
Yu Hong, Jiang Long, Hai Li, Shuhong Chen, Qiqi Liu, Bei Zhang, Xiaomin He, Yan Wang, Hongyi Li, Yimei Li, Tao Zhang, Chenzhen Lu, Hao Yan, Minli Zhang, Qing Li, Bangwei Cao, Zhigang Bai, Jin Wang, Zhongtao Zhang, Shengtao Zhu, Jiasheng Zheng, Xiaojuan Ou, Hong Ma, Jidong Jia, Hong You, Shengqi Wang, Jian Huang. An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma. EBioMedicine 2015; 2(5): 438 doi: 10.1016/j.ebiom.2015.03.010
|
| 41 |
Kai Chen, Zhuqing Zhang, Aijun Yu, Jian Li, Jinlong Liu, Xuejun Zhang, Abdelwahab Omri. lncRNA DLGAP1‐AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR‐154‐5p Methylation. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/6575724
|
| 42 |
Jon Olav Grepstad, Peter Kaspar, Olav Solgaard, Ib-Rune Johansen, Aasmund S. Sudbø. Photonic-crystal membranes for optical detection of single nano-particles, designed for biosensor application. Optics Express 2012; 20(7): 7954 doi: 10.1364/OE.20.007954
|
| 43 |
Meng-Yuan Yang, Fan Wu, Feng Fang, Hao Yang, Jing-Fan Zhang, Guo-Dong Chen, Lian-Yue Yang. Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08491-3
|
| 44 |
Haishun Liu, Zhenwei Zhang, Xin Zhang, Yuping Yang, Zhuoyong Zhang, Xiangyi Liu, Fan Wang, Yiding Han, Cunlin Zhang. Dimensionality Reduction for Identification of Hepatic Tumor Samples Based on Terahertz Time-Domain Spectroscopy. IEEE Transactions on Terahertz Science and Technology 2018; 8(3): 271 doi: 10.1109/TTHZ.2018.2813085
|
| 45 |
GuanXiong Ye, Yong Qin, Shi Wang, DeBiao Pan, ShengQian Xu, ChengJun Wu, XinMei Wang, Jun Wang, HaiLin Ye, HeJuan Shen. Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway. Cancer Biology & Therapy 2019; 20(5): 711 doi: 10.1080/15384047.2018.1564558
|
| 46 |
Ming Chen, Tenghao Zheng, Shuangyin Han, Lida Zhang, Yangqiu Bai, Xinhui Fang, Song-Ze Ding, Yuxiu Yang. A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients. Clinics and Research in Hepatology and Gastroenterology 2015; 39(2): 215 doi: 10.1016/j.clinre.2014.08.006
|
| 47 |
Suayib Yalcin, Sahin Lacin, Ahmed Kaseb, Bora Peynircioğlu, Murat Cantasdemir, Barbaros Çil, Pervin Hurmuz, Ahmet Doğrul, Murat Bozkurt, Hüseyin Abali, Okan Akhan, Halis Şimşek, Berksoy Sahin, Faruk Aykan, İdris Yücel, Gürkan Tellioğlu, Fatih Selçukbiricik, Philip Philip. A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements. Journal of Hepatocellular Carcinoma 2024; : 953 doi: 10.2147/JHC.S449540
|
| 48 |
Zhejia Zhang, Linyong Xu, Zhiming Wang. Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique. Journal of Clinical Laboratory Analysis 2011; 25(6): 402 doi: 10.1002/jcla.20491
|
| 49 |
Maryam H. Al-Zahrani, Maha J. Balgoon, Nagwa M. El-Sawi, Fawzia A. Alshubaily, Ebtihaj J. Jambi, Sohair M. Khojah, Raghad S. Baljoon, Nuha A. Alkhattabi, Lina A. Baz, Asmaa A. Alharbi, Amira M. Ahmed, Ayat M. Abo elkhair, Mohamed Ismael, Sahar M. Gebril. A biochemical, theoretical and immunohistochemical study comparing the therapeutic efficacy of curcumin and taurine on T-2 toxin induced hepatotoxicity in rats. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1172403
|
| 50 |
EMILIA HADZIYANNIS, KONSTANTINOS SIALEVRIS, ANASTASIA GEORGIOU, JOHN KOSKINAS. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels. Oncology Reports 2013; 29(2): 835 doi: 10.3892/or.2012.2147
|
| 51 |
Nada H Eisa, Mohamed A Ebrahim, Maha Ragab, Laila A Eissa, Amal M El-gayar. Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma. Journal of Oncology Pharmacy Practice 2015; 21(5): 323 doi: 10.1177/1078155214532698
|
| 52 |
Dimitrios Dimitroulis, Christos Damaskos, Serena Valsami, Spyridon Davakis, Nikolaos Garmpis, Eleftherios Spartalis, Antonios Athanasiou, Demetrios Moris, Stratigoula Sakellariou, Stylianos Kykalos, Gerasimos Tsourouflis, Anna Garmpi, Ioanna Delladetsima, Konstantinos Kontzoglou, Gregory Kouraklis. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World Journal of Gastroenterology 2017; 23(29): 5282-5294 doi: 10.3748/wjg.v23.i29.5282
|
| 53 |
Hyunsoo Kim, Kyunggon Kim, Su Jong Yu, Eun Sun Jang, Jiyoung Yu, Geunhee Cho, Jung-Hwan Yoon, Youngsoo Kim, Xin Wei Wang. Development of Biomarkers for Screening Hepatocellular Carcinoma Using Global Data Mining and Multiple Reaction Monitoring. PLoS ONE 2013; 8(5): e63468 doi: 10.1371/journal.pone.0063468
|
| 54 |
Iman A. Abd El Gawad, Ghada I. Mossallam, Noha H. Radwan, Heba M. Elzawahry, Niveen M. Elhifnawy. Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients. Journal of the Egyptian National Cancer Institute 2014; 26(2): 79 doi: 10.1016/j.jnci.2014.01.001
|
| 55 |
Young Hee Kim, Jin Seok Kang. Expression of Glypican-3 in Mouse Embryo Stem Cells and its Derived Hepatic Lineage Cells Treated with Diethylnitrosamine in vitro. Asian Pacific Journal of Cancer Prevention 2013; 14(11): 6341 doi: 10.7314/APJCP.2013.14.11.6341
|
| 56 |
M Laudien, R Häsler, J Wohlers, J Böck, S Lipinski, L Bremer, R Podschun, P Ambrosch, P Lamprecht, P Rosenstiel, A Till. Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis. Mucosal Immunology 2011; 4(5): 564 doi: 10.1038/mi.2011.9
|
| 57 |
Rafael Andres Ibarra, R. Abbas, R. S. Kombu, Guo-Fang Zhang, G. Jacobs, Z. Lee, H. Brunengraber, J. R. Sanabria. Disturbances in the Glutathione/Ophthalmate Redox Buffer System in the Woodchuck Model of Hepatitis Virus-Induced Hepatocellular Carcinoma. HPB Surgery 2011; 2011: 1 doi: 10.1155/2011/789323
|
| 58 |
Mohamed M Darweish, Ahmed Abbas, Mohamed A Ebrahim, Mohammed M H Al-Gayyar. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway. Journal of Pharmacy and Pharmacology 2014; 66(7): 1032 doi: 10.1111/jphp.12229
|
| 59 |
Juqiang Han, Jiarui Li, Yun Qian, Wenpeng Liu, Jiguang Liang, Zhigang Huang, Shuai Wang, Caiyan Zhao. Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2019; 43(5): 585 doi: 10.1016/j.clinre.2018.12.008
|
| 60 |
Faten Zahran Mohamed, Yousry Mostafa Hussein, Ibrahim Mohey El-Deen, Marwa Sayed Sabea. Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt. Molecular Biology Reports 2014; 41(3): 1461 doi: 10.1007/s11033-013-2991-7
|
| 61 |
Xin-sheng Cheng, Shi-bo Sun, Feng Zhong, Kun He, Jie Zhou. Knockdown of Histone Methyltransferase hSETD1A Inhibits Progression, Migration, and Invasion in Human Hepatocellular Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016; 24(4): 239 doi: 10.3727/096504016X14648701448011
|
| 62 |
Hao Xing, Haibo Qiu, Xuemei Ding, Jun Han, Zhenli Li, Han Wu, Cunling Yan, Huijun Li, Ruilin Han, Han Zhang, Chao Li, Mingda Wang, Mengchao Wu, Feng Shen, Yijie Zheng, Tian Yang. Clinical Performance of α-L-Fucosidase for Early Detection of Hepatocellular Carcinoma. Biomarkers in Medicine 2019; 13(7): 545 doi: 10.2217/bmm-2018-0414
|
| 63 |
Madhvi Patel, Mohamed I.F. Shariff, Nimzing G. Ladep, Andrew V. Thillainayagam, Howard C. Thomas, Shahid A. Khan, Simon D. Taylor‐Robinson. Hepatocellular carcinoma: diagnostics and screening. Journal of Evaluation in Clinical Practice 2012; 18(2): 335 doi: 10.1111/j.1365-2753.2010.01599.x
|
| 64 |
Keun Na, Seul‐Ki Jeong, Min Jung Lee, Sang Yun Cho, Sun A Kim, Min‐Ji Lee, Si Young Song, Hoguen Kim, Kyung Sik Kim, Hyun Woong Lee, Young‐Ki Paik. Human liver carboxylesterase 1 outperforms alpha‐fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients. International Journal of Cancer 2013; 133(2): 408 doi: 10.1002/ijc.28020
|
| 65 |
R. Anghel. Hepatocellular carcinoma – a challenge for oncologists. memo - Magazine of European Medical Oncology 2010; 3(3): 97 doi: 10.1007/s12254-010-0209-4
|
| 66 |
Heqing Huang, Min Zhang, Hong Lu, Yiling Chen, Weijie Sun, Jinghan Zhu, Zutao Chen. Identification and evaluation of plasma exosome RNA biomarkers for non-invasive diagnosis of hepatocellular carcinoma using RNA-seq. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13332-0
|
| 67 |
Weihao Kong, Xiaomin Zuo, Hao Liang, Jingxiong Hu, Huabing Zhang, Xingyu Wang, Wei Chen. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/1723184
|
| 68 |
Fei Zhao, Jin Zhao, Lei Song, Ya-Qing Zhang, Zhong Guo, Ke-Hu Yang. The induction of apoptosis and autophagy in human hepatoma SMMC-7721 cells by combined treatment with vitamin C and polysaccharides extracted from Grifola frondosa
. Apoptosis 2017; 22(11): 1461 doi: 10.1007/s10495-017-1421-z
|
| 69 |
Yousra M. El-Far, Ahmed E. Khodir, Ahmad O. Noor, Deina M. Almasri, Alaa A. Bagalagel, Reem M. Diri, Hussam I. Kutbi, Mohammed M. H. Al-Gayyar. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis in vivo and in vitro. Redox Report 2020; 25(1): 17 doi: 10.1080/13510002.2020.1739870
|
| 70 |
John M. Luk, Angela M. Liu. Proteomics of Hepatocellular Carcinoma in Chinese Patients. OMICS: A Journal of Integrative Biology 2011; 15(5): 261 doi: 10.1089/omi.2010.0099
|
| 71 |
Ahmed M. Tahon, Magdy Z. El-Ghanam, Samy Zaky, Tarek Mostafa Emran, Ali M. Bersy, Fathiya El-Raey, Elsayed A.Z., Amr M. El Kharsawy, Dina Johar. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients. Journal of Gastrointestinal Cancer 2019; 50(3): 434 doi: 10.1007/s12029-018-0095-2
|
| 72 |
Chiaki Nagai-Okatani, Naoto Minamino, Randall Lee Rasmusson. Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure. PLOS ONE 2016; 11(6): e0150210 doi: 10.1371/journal.pone.0150210
|
| 73 |
Hassnaa M. Ibrahim, Magdy Z. Elghannam, Om Ali Y. Elkhawaga, Ahmed M.A. El-Sokkary. Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients. Saudi Journal of Biological Sciences 2021; 28(10): 5760 doi: 10.1016/j.sjbs.2021.06.020
|
| 74 |
Lu Wen, Jingyi Li, Huahu Guo, Xiaomeng Liu, Shengmin Zheng, Dafang Zhang, Weihua Zhu, Jianhui Qu, Limin Guo, Dexiao Du, Xiao Jin, Yuhao Zhang, Yun Gao, Jie Shen, Hao Ge, Fuchou Tang, Yanyi Huang, Jirun Peng. Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients. Cell Research 2015; 25(11): 1250 doi: 10.1038/cr.2015.126
|
| 75 |
Felix H. Shek, Tracy C. W. Lai, Sarwat Fatima, Nikki P. Lee. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. 2013; : 57 doi: 10.1007/978-1-62703-456-2_4
|
| 76 |
Tao Huang, Qi-Feng Chen, Bo-Yang Chang, Lu-Jun Shen, Wang Li, Pei-Hong Wu, Wei-Jun Fan. TFAP4 Promotes Hepatocellular Carcinoma Invasion and Metastasis via Activating the PI3K/AKT Signaling Pathway. Disease Markers 2019; 2019: 1 doi: 10.1155/2019/7129214
|
| 77 |
Lei Xi, Chunqing Yang. Evaluation of alpha-l-fucosidase for the diagnosis of hepatocellular carcinoma based on meta-analysis. Journal of Laboratory Medicine 2020; 44(4): 183 doi: 10.1515/labmed-2019-0152
|
| 78 |
Frank E. Luke, Brian C. Allen, Sara T. Moshiri, Lisa M. Ho, Christopher M. Massey, Sandra S. Stinnett, Andrew J. Muir, Tracy A. Jaffe. Multiphase Multi–Detector Row Computed Tomography in the Setting of Chronic Liver Disease and Orthotopic Liver Transplantation. Journal of Computer Assisted Tomography 2013; 37(3): 408 doi: 10.1097/RCT.0b013e3182838680
|
| 79 |
Jing Fu, Hongyang Wang. Precision diagnosis and treatment of liver cancer in China. Cancer Letters 2018; 412: 283 doi: 10.1016/j.canlet.2017.10.008
|
| 80 |
Hai-Yuan FU, Jian YUAN, Xiao-Ming ZHOU, Yun-Bo SUN, Ya-Juan HUANG, Li-Ping HOU, Chun-Yan SONG, Bao-An YANG, Pei ZHEN, Rong GAO, Pan-Yong MAO, Li-Zhong LIN, Shu-Fang XU, Han-Zu XIAO, Kai-Hua WEI. Determination of Hepatocellular Carcinoma Serum Polypeptide Based on Antibody Pre-concentration Coupled with Mass Spectrometry. Chinese Journal of Analytical Chemistry 2012; 40(12): 1803 doi: 10.1016/S1872-2040(11)60590-2
|
| 81 |
Ali Alshati, Sharad Bellapravalu, Indu Srinivasan, Abdul Nadir, Keng-Yu Chuang. Imaging-Negative Hepatocellular Carcinoma Presents as an Intrabiliary Mass. ACG Case Reports Journal 2019; 6(5): e00068 doi: 10.14309/crj.0000000000000068
|
| 82 |
Ke-Qi Han, Xue-Qun He, Meng-Yu Ma, Xiao-Dong Guo, Xue-Min Zhang, Jie Chen, Hui Han, Wei-Wei Zhang, Quan-Gang Zhu, Hua Nian, Li-Jun Ma. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(16): 4864-4874 doi: 10.3748/wjg.v21.i16.4864
|
| 83 |
Ahmed Ramadan, Ashraf Omar Abdelaziz, Dina Sabry, Shaimaa Abd El tawab Fathi, Mohamed Mahmoud Nabeel, Hend Ibrahim Shousha, Tamer Mahmoud Elbaz, Rania mohamed Lithy, Hoda Ramadan Ryed. Study on molecular expression of long non-coding RNA Glypican3 in hepatocellular cancer patients. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00221-z
|
| 84 |
Shahira S. ElGemei, Noha M. Shaheen, Reham Emad Abu Khalil. The association between heat shock protein P2/P2 genotype with Egyptian hepatocellular carcinoma patients. Comparative Clinical Pathology 2013; 22(6): 1183 doi: 10.1007/s00580-012-1547-x
|
| 85 |
Abdullah Alyoussef, Mohammed M H Al-Gayyar. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Biomedicine & Pharmacotherapy 2018; 103: 362 doi: 10.1016/j.biopha.2018.04.060
|
| 86 |
Masahiro Ohgidani, Hideaki Ichihara, Koichi Goto, Yoko Matsumoto, Ryuichi Ueoka. Anticancer Effects of Residual Powder from Barley-<i>Shochu</i> Distillation Remnants against the Orthotopic Xenograft Mouse Models of Hepatocellular Carcinoma <i>in Vivo</i>. Biological and Pharmaceutical Bulletin 2012; 35(6): 984 doi: 10.1248/bpb.35.984
|
| 87 |
Linshun Xie, Tianhua Li, Futao Hu, Qianli Jiang, Qiqin Wang, Ning Gan. A novel microfluidic chip and antibody-aptamer based multianalysis method for simultaneous determination of several tumor markers with polymerization nicking reactions for homogenous signal amplification. Microchemical Journal 2019; 147: 454 doi: 10.1016/j.microc.2019.03.028
|
| 88 |
Xiao-Hong Ma, Shuang Wang, Si-Yun Liu, Kun Chen, Zhi-Yuan Wu, Deng-Feng Li, Yong-Tao Mi, Long-Bin Hu, Zhong-Wei Chen, Xin-Ming Zhao. Development and <i>in vitro</i> study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(24): 3030-3043 doi: 10.3748/wjg.v25.i24.3030
|
| 89 |
Masahiro Ohgidani, Yuji Komizu, Koichi Goto, Ryuichi Ueoka. Residual powders from Shochu distillation remnants induce apoptosis in human hepatoma cells via the caspase-independent pathway. Journal of Bioscience and Bioengineering 2012; 114(1): 104 doi: 10.1016/j.jbiosc.2012.02.026
|
| 90 |
Yanrui Sheng, Jianbo Li, Chengcheng Zou, Sen Wang, Yiyi Cao, Jingnan Zhang, Ailong Huang, Hua Tang. Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a. Archives of Virology 2014; 159(9): 2397 doi: 10.1007/s00705-014-2084-5
|
| 91 |
C.-C. Liu, H. Yang, R. Zhang, J.-J. Zhao, D.-J. Hao. Tumour-associated antigens and their anti-cancer applications. European Journal of Cancer Care 2017; 26(5): e12446 doi: 10.1111/ecc.12446
|
| 92 |
Shouzhang Yang, Huajie Cai, Bingren Hu, Jinfu Tu. LncRNA SAMMSON negatively regulates miR-9-3p in hepatocellular carcinoma cells and has prognostic values. Bioscience Reports 2019; 39(7) doi: 10.1042/BSR20190615
|
| 93 |
Matthew B. West, Marie H. Hanigan. γ-Glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells. Archives of Biochemistry and Biophysics 2010; 504(2): 177 doi: 10.1016/j.abb.2010.08.019
|
| 94 |
Yaping Shao, Bin Zhu, Ruiyin Zheng, Xinjie Zhao, Peiyuan Yin, Xin Lu, Binghua Jiao, Guowang Xu, Zhenzhen Yao. Development of Urinary Pseudotargeted LC-MS-Based Metabolomics Method and Its Application in Hepatocellular Carcinoma Biomarker Discovery. Journal of Proteome Research 2015; 14(2): 906 doi: 10.1021/pr500973d
|
| 95 |
Hyoung-Joo Lee, Hyun-Jeong Cha, Jong-Sun Lim, Sun Hee Lee, Si Young Song, Hoguen Kim, William S. Hancock, Jong Shin Yoo, Young-Ki Paik. Abundance-Ratio-Based Semiquantitative Analysis of Site-Specific N-Linked Glycopeptides Present in the Plasma of Hepatocellular Carcinoma Patients. Journal of Proteome Research 2014; 13(5): 2328 doi: 10.1021/pr4011519
|
| 96 |
Xiao-Fei Liu, Zhi-De Hu, Xiao-Cui Liu, Yuan Cao, Chun-Mei Ding, Cheng-Jin Hu. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: A systematic review and meta-analysis. Clinical Biochemistry 2014; 47(3): 196 doi: 10.1016/j.clinbiochem.2013.12.007
|
| 97 |
Areeg M. Dabbish, Hana M. Abdelzaher, Moustafa Abohawya, Samir Shamma, Yosra H. Mahmoud, Amr Maged, Mohamed Manaa, Mohamed Hassany, Firas Kobeissy, Omid Bazgir, Hassan El-Fawal, Hassan M. E. Azzazy, Anwar Abdelnaser. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation. Cancers 2022; 14(13): 3036 doi: 10.3390/cancers14133036
|
| 98 |
Yuling Gan, Qiuzhen Liang, Xinghua Song. Diagnostic value of alpha-l-fucosidase for hepatocellular carcinoma: a meta-analysis. Tumor Biology 2014; 35(5): 3953 doi: 10.1007/s13277-013-1563-8
|
| 99 |
Guo-Jian Li, Qin-Yan Chen, Tim J. Harrison, Xue-Yan Wang, Li-Ping Hu, Qing-Li Yang, Kai-Wen Li, Zhong-Liao Fang. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study. Cancer Biomarkers 2017; 18(3): 241 doi: 10.3233/CBM-160131
|
| 100 |
Marwa Ahmed Sakr, Khaled Abdel Hamid Mohamed, Ahmed Mohamed Hussein, Mohamed Hassan Fouad, Ahmed Samir Allam, Eslam Safwat. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00090-y
|
| 101 |
F. Rauchfuss, H. Scheuerlein, M. Götz, Y. Dittmar, R. Voigt, M. Heise, U. Settmacher. Hepatozelluläres Karzinom und Cholangiokarzinom. Der Chirurg 2010; 81(10): 941 doi: 10.1007/s00104-009-1864-z
|
| 102 |
Maria Tampaki, Polyxeni P Doumba, Melanie Deutsch, John Koskinas. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights. World Journal of Hepatology 2015; 7(14): 1834-1842 doi: 10.4254/wjh.v7.i14.1834
|
| 103 |
Goshi Shiota, Norimasa Miura. Biomarkers for hepatocellular carcinoma. Clinical Journal of Gastroenterology 2012; 5(3): 177 doi: 10.1007/s12328-012-0301-x
|
| 104 |
Nadia I. Zakhary, Sherif M. Khodeer, Hanan E. Shafik, Camelia A. Abdel Malak. Impact of PIVKA-II in diagnosis of hepatocellular carcinoma. Journal of Advanced Research 2013; 4(6): 539 doi: 10.1016/j.jare.2012.10.004
|
| 105 |
Ningtao Cheng, Jing Fu, Dajing Chen, Shuzhen Chen, Hongyang Wang. An antibody-free liver cancer screening approach based on nanoplasmonics biosensing chips via spectrum-based deep learning. NanoImpact 2021; 21: 100296 doi: 10.1016/j.impact.2021.100296
|
| 106 |
Chenjun Huang, Xiao Xiao, Lin Zhou, Fuxiang Chen, Jianyi Wang, Xiaobo Hu, Chunfang Gao. Chinese expert consensus statement on the clinical application of AFP/AFP‐L3%/DCP using GALAD and GALAD‐like algorithm in HCC. Journal of Clinical Laboratory Analysis 2023; 37(23-24) doi: 10.1002/jcla.24990
|
| 107 |
Juan Chen, Zhenwen Qian, Fengling Li, Jinzhi Li, Yi Lu. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma. Gut and Liver 2017; 11(1): 112 doi: 10.5009/gnl16063
|
| 108 |
Bin Hu, Xiaohui Tian, Jie Sun, Xiangjun Meng. Evaluation of Individual and Combined Applications of Serum Biomarkers for Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. International Journal of Molecular Sciences 2013; 14(12): 23559 doi: 10.3390/ijms141223559
|
| 109 |
Guifang Chen, Shengfa Ni, Sha Zhu, Jinghua Yang, Yongmei Yin. An Electrochemical Method to Detect Gamma Glutamyl Transpeptidase. International Journal of Molecular Sciences 2012; 13(3): 2801 doi: 10.3390/ijms13032801
|
| 110 |
Mahmoud Khattab, Magdy Fouad, Elham Ahmed. Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(23): 2474-2481 doi: 10.4254/wjh.v7.i23.2474
|
| 111 |
Sufen Shang, Amelie Plymoth, Shaokui Ge, Ziding Feng, Hugo R. Rosen, Suleeporn Sangrajrang, Pierre Hainaut, Jorge A. Marrero, Laura Beretta. Identification of Osteopontin as a Novel Marker for Early Hepatocellular Carcinoma. Hepatology 2012; 55(2): 483 doi: 10.1002/hep.24703
|
| 112 |
Adriana Unić, Lovorka Derek, Marko Duvnjak, Leonardo Patrlj, Mislav Rakić, Milan Kujundžić, Vesna Renjić, Nikola Štoković, Petra Dinjar, Anita Jukic, Ivica Grgurević. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(3): 355 doi: 10.1177/0004563217726808
|
| 113 |
Dharsini Narayana Moorthy, Durgalakshmi Dhinasekaran, P. N. Blessy Rebecca, Ajay Rakkesh Rajendran. Optical Biosensors for Detection of Cancer Biomarkers: Current and Future Perspectives. Journal of Biophotonics 2024; 17(12) doi: 10.1002/jbio.202400243
|
| 114 |
Chaoyang Liu, Ke Gong, Xin Mao, Wenhua Li. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. International Journal of Cancer 2011; 129(6): 1519 doi: 10.1002/ijc.25817
|
| 115 |
Tarek D. Hussein. Serological tumor markers of hepatocellular carcinoma: a meta-analysis. The International Journal of Biological Markers 2015; 30(1): 32 doi: 10.5301/jbm.5000119
|
| 116 |
Liang Li, Hongyang Wang. Heterogeneity of liver cancer and personalized therapy. Cancer Letters 2016; 379(2): 191 doi: 10.1016/j.canlet.2015.07.018
|
| 117 |
Ashraf Khalil, Jamalat Elgedawy, Mohammed F Faramawi, Ashraf Elfert, Ibrahim Salama, Ahmed Abbass, Hala Elsaid, Hatem Elsebaai. Plasma Osteopontin Level as a Diagnostic Marker of Hepatocellular Carcinoma in Patients with Radiological Evidence of Focal Hepatic Lesions. Tumori Journal 2013; 99(1): 100 doi: 10.1177/030089161309900117
|
| 118 |
Wen-Yea Yau, Han-Chun Shih, Mong-Hsun Tsai, Jin-Chuan Sheu, Chien-Hung Chen, Lu-Ping Chow. Autoantibody recognition of an N-terminal epitope of hnRNP L marks the risk for developing HBV-related hepatocellular carcinoma. Journal of Proteomics 2013; 94: 346 doi: 10.1016/j.jprot.2013.10.003
|
| 119 |
Hao Yang, Guo-Dong Chen, Feng Fang, Zhen Liu, Stephanie Hiu Yan Lau, Jin-Fan Zhang, Wan Yee Lau, Lian-Yue Yang. Dickkopf-1: As a Diagnostic and Prognostic Serum Marker for Early Hepatocellular Carcinoma. The International Journal of Biological Markers 2013; 28(3): 286 doi: 10.5301/JBM.5000015
|
| 120 |
Dalia Omran, Serag Esmat, Heba Sedrac, Ahmad ElBadry, Dina Ismail, Laila Rashed. Can we use GP73 as a biomarker for the detection of hepatocellular carcinoma?. Egyptian Liver Journal 2011; 1(1): 43 doi: 10.1097/01.ELX.0000397027.33294.16
|
| 121 |
Salah Elgamal, Ahmed A. Ghafar, Elsayed Ghoneem, Moustafa Elshaer, Hani Alrefai, Wafaa Elemshaty. Characterization of patients with hepatocellular carcinoma on the way for early detection: one center experience. The Egyptian Journal of Internal Medicine 2018; 30(4): 231 doi: 10.4103/ejim.ejim_29_18
|
| 122 |
Lihong Li, Wen Shi, Zhe Wang, Qiuyu Gong, Huimin Ma. Sensitive Fluorescence Probe with Long Analytical Wavelengths for γ-Glutamyl Transpeptidase Detection in Human Serum and Living Cells. Analytical Chemistry 2015; 87(16): 8353 doi: 10.1021/acs.analchem.5b01535
|
| 123 |
Maissa El Raziky, Hanan Abdel Hafez, Aisha Elsharkawy, Tarek Ahmed Moneer, Suzan M. EL-Sheikh, Rabab M. Maher, Sahar A. Sharaf. Serum level of cytokeratin 19 as a diagnostic and prognostic marker in patients with HCV-related hepatocellular carcinoma. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00125-4
|
| 124 |
Amira Isaac, Sherif Mounir Mohamed, Osama Ashraf Ahmed, Ahmed Gamal Mohamed Hassan, Hany Samir Rasmy. Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment. The Egyptian Journal of Internal Medicine 2021; 33(1) doi: 10.1186/s43162-021-00078-5
|
| 125 |
Jason K. Sicklick, Michael D’Angelica, Yuman Fong. Sabiston Textbook of Surgery. 2012; : 1411 doi: 10.1016/B978-1-4377-1560-6.00054-8
|
| 126 |
Qi-Wen Li, Hong-Bing Chen, Zhi-Yang Li, Peng Shen, Li-Li Qu, Lai-Ling Gong, Hong-Pan Xu, Lu Pang, Jin Si. Preparation and Characterization of Anti-GP73 Monoclonal Antibodies and Development of Double-antibody Sandwich ELISA. Asian Pacific Journal of Cancer Prevention 2015; 16(5): 2043 doi: 10.7314/APJCP.2015.16.5.2043
|
| 127 |
TingTing Qi, JinFeng Liao, YiSong Li, JinRong Peng, WenTing Li, BingYang Chu, He Li, YuQuan Wei, ZhiYong Qian. Label-free alpha fetoprotein immunosensor established by the facile synthesis of a palladium–graphene nanocomposite. Biosensors and Bioelectronics 2014; 61: 245 doi: 10.1016/j.bios.2014.05.021
|
| 128 |
Chang-Liang Luo, Yuan Rong, Hao Chen, Wu-Wen Zhang, Long Wu, Diao Wei, Xiu-Qi Wei, Lie-Jun Mei, Fu-Bing Wang. A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819846632
|
| 129 |
V. S. Lisovska.
EXPRESSION OF GAMMA-GLUTAMYLTRANSFERASE IN RAT HEPATOCYTES EXPOSED TO GENERIC CARBENDAZIM ON THE MODEL OF «NDEA- HEPATECTOMY»
. Bulletin of Problems Biology and Medicine 2020; 4(2): 130 doi: 10.29254/2077-4214-2019-4-2-154-130-135
|
| 130 |
Zhaohua Ping, Hui Xu, Ting Liu, Junchao Huang, Yan Meng, Xiaojuan Xu, Wenhua Li, Lina Zhang. Anti-hepatoma activity of the stiff branched β-d-glucan and effects of molecular weight. Journal of Materials Chemistry B 2016; 4(26): 4565 doi: 10.1039/C6TB01299J
|